BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17656357)

  • 1. Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration.
    Sun JP; Luo Y; Yu X; Wang WQ; Zhou B; Liang F; Zhang ZY
    J Biol Chem; 2007 Sep; 282(39):29043-29051. PubMed ID: 17656357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
    Luo Y; Liang F; Zhang ZY
    Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
    Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
    Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
    Dong J; Sui L; Wang Q; Chen M; Sun H
    Mol Med Rep; 2014 Sep; 10(3):1426-32. PubMed ID: 24939702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
    Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
    Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of the PRL phosphatases.
    Rios P; Li X; Köhn M
    FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.
    Bai Y; Yu ZH; Liu S; Zhang L; Zhang RY; Zeng LF; Zhang S; Zhang ZY
    Cancer Res; 2016 Aug; 76(16):4805-15. PubMed ID: 27325652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.
    Skinner AL; Vartia AA; Williams TD; Laurence JS
    Biochemistry; 2009 May; 48(20):4262-72. PubMed ID: 19341304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
    Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q
    PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
    Reich R; Hadar S; Davidson B
    Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
    Achiwa H; Lazo JS
    Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
    Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
    Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting PRL phosphatases in hematological malignancies.
    Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
    Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL).
    Ishii T; Funato Y; Miki H
    J Biol Chem; 2013 Mar; 288(10):7263-70. PubMed ID: 23362275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.
    Lou X; Liu Y; Lei JY; Li H
    Cell Biol Int; 2012 Aug; 36(8):759-63. PubMed ID: 22551255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis.
    Bai Y; Zhou HM; Zhang L; Dong Y; Zeng Q; Shou W; Zhang ZY
    Sci Rep; 2016 Sep; 6():34211. PubMed ID: 27666520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
    Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
    Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.